PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.55%
Negative revenue growth while 5715.T stands at 3.46%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.47%
Negative gross profit growth while 5715.T is at 4.29%. Joel Greenblatt would examine cost competitiveness or demand decline.
-126.96%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-55.36%
Negative operating income growth while 5715.T is at 2.27%. Joel Greenblatt would press for urgent turnaround measures.
-84.48%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-84.49%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-84.49%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 5715.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.95%
Negative 10Y revenue/share CAGR while 5715.T stands at 34.90%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-22.05%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
44.72%
3Y revenue/share CAGR above 1.5x 5715.T's 26.20%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-100.00%
Negative 10Y OCF/share CAGR while 5715.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-125.86%
Negative 10Y net income/share CAGR while 5715.T is at 423.86%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-292.56%
Negative 5Y net income/share CAGR while 5715.T is 46.55%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-127.27%
Negative 3Y CAGR while 5715.T is 329.17%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-57.46%
Negative equity/share CAGR over 10 years while 5715.T stands at 66.94%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
45.34%
5Y equity/share CAGR is in line with 5715.T's 43.27%. Walter Schloss would see parallel mid-term profitability and retention policies.
40.54%
3Y equity/share CAGR above 1.5x 5715.T's 22.38%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.80%
Firm’s AR is declining while 5715.T shows 1.35%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
22.19%
We show growth while 5715.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
9.61%
Positive asset growth while 5715.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-2.64%
We have a declining book value while 5715.T shows 0.14%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
16.75%
We have some new debt while 5715.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Our R&D shrinks while 5715.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-5.12%
We cut SG&A while 5715.T invests at 5.34%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.